Advertisement

Surgery Today

, Volume 45, Issue 2, pp 162–167 | Cite as

Endovascular treatment for unilateral chronic total occlusions of the iliac artery categorized as TASC II type D lesions

  • Naokazu Miyamoto
  • Ryota Kawasaki
  • Tetsuya Fukuda
  • Masato Yamaguchi
  • Kazuro Sugimura
  • Koji Sugimoto
Original Article
  • 224 Downloads

Abstract

Purpose

To compare the results of endovascular treatment for unilateral iliac occlusion in types B and D, and confirm its validity for type D.

Methods

Between 2000 and 2011, 108 patients underwent endovascular treatment for unilateral iliac occlusion. 77 were categorized as type B for occlusion of common iliac artery (CIA) or external iliac artery (EIA) and 31 were categorized as type D for occlusion of both CIA and EIA. The initial success rates, procedure time, penetration time, amount of contrast media used, complication rates, and cumulative primary patency rates were determined and compared between these groups.

Results

Between type D and B groups, the initial success rates were 87.1 % (type D) and 89.6 % (type B) (p = 0.9316). The procedure time was 137.0 ± 55.5 and 97.2 ± 47.2 min (p < 0.05). The penetration time was 49.1 ± 40.6 and 31.6 ± 30.1 min (p < 0.05). The amount of contrast agent used was 193.9 ± 103.1 and 156.5 ± 85.0 ml (p = 0.0722). The complication rates were 6.5 and 3.9 % (p = 0.8491). The cumulative primary patency rates, at 1, 3, and 5 years were 91, 85, and 85 % and 100, 96, and 93 %.

Conclusion

Endovascular treatment can be indicated for unilateral occlusion of both CIA and EIA categorized as type D.

Keywords

Peripheral arterial disease Iliac artery Occlusion Percutaneous transluminal angioplasty Stenting 

Notes

Conflict of interest

Naokazu Miyamoto and other co-authors have no conflict of interest.

References

  1. 1.
    Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, TASC II Working Group. Inter-Society Consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45(Suppl S):S5–67.PubMedCrossRefGoogle Scholar
  2. 2.
    Leville CD, Kashyap VS, Clair DG, Bena JF, Lyden SP, Greenberg RK, O’Hara PJ, Sarac TP, Ouriel K. Endovascular management of iliac artery occlusions: extending treatment to Trans-Atlantic Inter-Society Consensus class C and D patients. J Vasc Surg. 2006;43(1):32–9.PubMedCrossRefGoogle Scholar
  3. 3.
    Sixt S, Alawied AK, Rastan A, Schwarzwälder U, Kleim M, Noory E, Schwarz T, Frank U, Müller C, Hauk M, Beschorner U, Nazary T, Bürgelin K, Hauswald K, Leppänen O, Neumann FJ, Zeller T. Acute and long-term outcome of endovascular therapy for aortoiliac occlusive lesions stratified according to the TASC classification: a single-center experience. J Endovasc Ther. 2008;15(4):408–16.PubMedCrossRefGoogle Scholar
  4. 4.
    Koizumi A, Kumakura H, Kanai H, Araki Y, Kasama S, Sumino H, Ichikawa S, Kurabayashi M. Ten-year patency and factors causing restenosis after endovascular treatment of iliac artery lesions. Circ J. 2009;73(5):860–6.PubMedCrossRefGoogle Scholar
  5. 5.
    Balzer JO, Gastinger V, Ritter R, Herzog C, Mack MG, Schmitz-Rixen T, Vogl TJ. Percutaneous interventional reconstruction of the iliac arteries: primary and long-term success rate in selected TASC C and D lesions. Eur Radiol. 2006;16(1):124–31.PubMedCrossRefGoogle Scholar
  6. 6.
    Ichihashi S, Higashiura W, Itoh H, Sakaguchi S, Nishimine K, Kichikawa K. Long-term outcomes for systematic primary stent placement in complex iliac artery occlusive disease classified according to Trans-Atlantic Inter-Society Consensus (TASC)-II. J Vasc Surg. 2011;53(4):992–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Kaneoka Y, Maeda A, Sugimoto M, Isogai M, Ishibashi H. Quality of life and the venous function of the lower limb after harvest of autologous external iliac vein grafts: a clinical follow-up study. Surg Today. 2013;43(11):1254–60.PubMedCrossRefGoogle Scholar
  8. 8.
    Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, Jones DN. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997;26(3):517–38.PubMedCrossRefGoogle Scholar
  9. 9.
    Staniloae CS, Mody KP, Yadav SS, Han SY, Korabathina R. Endoluminal treatment of peripheral chronic total occlusions using the Crosser® recanalization catheter. J Invasive Cardiol. 2011;23(9):359–62.PubMedGoogle Scholar
  10. 10.
    Krishnamurthy VN, Eliason JL, Henke PK, Rectenwald JE. Intravascular ultrasound-guided true lumen reentry device for recanalization of unilateral chronic total occlusion of iliac arteries: technique and follow-up. Ann Vasc Surg. 2010;24(4):487–97 [Epub 2010 Apr 2].PubMedCrossRefGoogle Scholar
  11. 11.
    Al-Ameri H, Shin V, Mayeda GS, Burstein S, Matthews RV, Kloner RA, Shavelle DM. Peripheral chronic total occlusions treated with subintimal angioplasty and a true lumen re-entry device. J Invasive Cardiol. 2009;21(9):468–72.PubMedGoogle Scholar
  12. 12.
    Paraskevas KI, Giannoukas AD, Mikhailidis DP. Renal function impairment in peripheral arterial disease: an important parameter that should not be neglected. Ann Vasc Surg. 2009;23(5):690–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Ozkan U, Oguzkurt L, Tercan F. Technique, complication, and long-term outcome for endovascular treatment of iliac artery occlusion. Cardiovasc Intervent Radiol. 2010;33(1):18–24.PubMedCrossRefGoogle Scholar
  14. 14.
    Gandini R, Fabiano S, Chiocchi M, Chiappa R, Simonetti G. Percutaneous treatment in iliac artery occlusion: long-term results. Cardiovasc Intervent Radiol. 2008;31(6):1069–76.PubMedCrossRefGoogle Scholar
  15. 15.
    Carnevale FC, De Blas M, Merino S, Egaña JM, Caldas JG. Percutaneous endovascular treatment of chronic iliac artery occlusion. Cardiovasc Intervent Radiol. 2004;27(5):447–52.PubMedGoogle Scholar
  16. 16.
    Uher P, Nyman U, Lindh M, Lindblad B, Ivancev K. Long-term results of stenting for chronic iliac artery occlusion. J Endovasc Ther. 2002;9(1):67–75.PubMedCrossRefGoogle Scholar
  17. 17.
    AbuRahma AF, Hayes JD, Flaherty SK, Peery W. Primary iliac stenting versus transluminal angioplasty with selective stenting. J Vasc Surg. 2007;46(5):965–70.PubMedCrossRefGoogle Scholar
  18. 18.
    van Adrichem LN, van Berge Henegouwen DP, Lobach HJ, van der Werken C. The femoro-femoral cross-over bypass. Neth J Surg. 1991;43(3):67–70.Google Scholar
  19. 19.
    Fahal AH, McDonald AM, Marston A. Femorofemoral bypass in unilateral iliac artery occlusion. Br J Surg. 1989;76(1):22–5.PubMedCrossRefGoogle Scholar
  20. 20.
    Aronow WS, Ahn C. Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women ≥62 years of age. Am J Cardiol. 1994;74(1):64–5.PubMedCrossRefGoogle Scholar
  21. 21.
    Rits J, van Herwaarden JA, Jahrome AK, Krievins D, Moll FL. The incidence of arterial stent fractures with exclusion of coronary, aortic, and non-arterial settings. Eur J Vasc Endovasc Surg. 2008;36(3):339–45.PubMedCrossRefGoogle Scholar
  22. 22.
    Lopez JF, Magne JL, Champetier J. The femoral artery and flexion of the hip joint. Surg Radiol Anat. 1989;11(4):275–81.PubMedCrossRefGoogle Scholar
  23. 23.
    Ballotta E, Gruppo M, Mazzalai F, Da Giau G. Common femoral artery endarterectomy for occlusive disease: an 8-year single-center prospective study. Surgery. 2010;147(2):268–74.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Japan 2014

Authors and Affiliations

  • Naokazu Miyamoto
    • 1
  • Ryota Kawasaki
    • 1
  • Tetsuya Fukuda
    • 3
  • Masato Yamaguchi
    • 2
  • Kazuro Sugimura
    • 2
  • Koji Sugimoto
    • 2
  1. 1.Department of RadiologyHyogo Brain and Heart Center at HimejiHimejiJapan
  2. 2.Department of Radiology and Center for Endovascular TherapyKobe University Graduate School of MedicineKobeJapan
  3. 3.Department of RadiologyNational Cerebral and Cardiovascular CenterOsakaJapan

Personalised recommendations